ConductScience.org, home

Paper4381702

A comparison of the antiarrhythmic actions of two new synthetic compounds, iproveratril and MJ 1999, with quinidine and pronethalol.

Schmid JR and 1 other. J Pharmacol Exp Ther, 1967. Cited by 141 papers, by iCite.

Cite this record

ConductScience Library. A comparison of the antiarrhythmic actions of two new synthetic compounds, iproveratril and MJ 1999, with quinidine and pronethalol. Papers, record 4381702. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4381702

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A comparison of the antiarrhythmic actions of two new synthetic compounds, iproveratril and MJ 1999, with quinidine and pronethalol.
PubMed
Journal
J Pharmacol Exp Ther
PubMed
Year
1967
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
141
iCite
Revised in PubMed
2013-11-21
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Schmid JRJ R
2Hanna CC

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Arrhythmia AgentsMajor topic
Arrhythmias, CardiacMajor topic
EthanolaminesMajor topic
QuinidineMajor topic
Aconitum
Animals
Blood Pressure
Coronary Vessels
Dogs
Electrocardiography
Epinephrine
Female
Heart Rate
Male
Ouabain
Tachycardia
Verapamil

Source PubMed

Download CSV of topics

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 141 citations.

PMIDTitleJournalYearIn PapersSource
37513889Antiarrhythmic Sotalol, Occlusion/Occlusion-like Syndrome in Rats, and Stable Gastric Pentadecapeptide BPC 157 Therapy.Pharmaceuticals (Basel)2023https://conductscience.org/library/papers/37513889PubMed
5485144A third class of anti-arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474.Br J Pharmacol1970https://conductscience.org/library/papers/5485144PubMed
5447137[Prevention of coplications in th combination of suprarenin infiltration with halothane and barbiturate anesthesia].Arch Klin Exp Ohren Nasen Kehlkopfheilkd1970https://conductscience.org/library/papers/5447137PubMed
4851712Effect of verapamil in obstructive airways disease.Eur J Clin Pharmacol1974https://conductscience.org/library/papers/4851712PubMed
4469035Verapamil in the treatment of paroxysmal supraventricular tachycardia.Postgrad Med J1974https://conductscience.org/library/papers/4469035PubMed
4397722General concepts in the use of beta-blockers: the relative roles of specific and unspecific effects.Naunyn Schmiedebergs Arch Pharmakol1971https://conductscience.org/library/papers/4397722PubMed
4397569Antiarrhythmic effects of dichloroisoprenaline, H 56-28, ICI 50172, LB 46, MJ 1999 and propranolol on aconitine-induced atrial and ouabain-induced ventricular arrhythmias.Experientia1971https://conductscience.org/library/papers/4397569PubMed
4392958Prejunctional actions of some beta-adrenoreceptor antagonists in the vas deferens preparation of the guinea-pig.Br J Pharmacol1970https://conductscience.org/library/papers/4392958PubMed
3315621Sotalol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.Drugs1987https://conductscience.org/library/papers/3315621PubMed
3154668What is the solution to sudden cardiac death: calcium modulation or arrhythmia clinics?Cardiovasc Drugs Ther1987https://conductscience.org/library/papers/3154668PubMed
2726684The antiarrhythmic activity of N-alkyl-1,2-diphenylethanolamines.Pharm Res1989https://conductscience.org/library/papers/2726684PubMed
1718690Protective effects of calcium antagonists against ischaemia and reperfusion damage.Drugs1991https://conductscience.org/library/papers/1718690PubMed
1207784
Optical isomers of verapamil on canine heart. Prevention of ventricular fibrillation induced by coronary artery occlusion, impaired atrioventricular conductance and negative inotropic and chronotropic effects.
Naunyn Schmiedebergs Arch Pharmacol1975https://conductscience.org/library/papers/1207784PubMed
346345Verapamil: a review of its pharmacological properties and therapeutic use.Drugs1978https://conductscience.org/library/papers/346345PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/4381702

GET https://conductscience.org/api/papers/v1/4381702/authors